Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Performance of routine risk scores for predicting cirrhosis-related morbidity in the community
Hamish Innes, Joanne R Morling, Stephan Buch, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 365-376
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 28
Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (2022), pp. n/a-n/a
Open Access | Times Cited: 53
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
Pierre Nahon, Jessica Bamba‐Funck, Richard Layese, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 584-595
Open Access | Times Cited: 41
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Timothy J. Kendall, Maria Jiménez Ramos, Frances Turner, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2939-2953
Open Access | Times Cited: 32
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease
Naga Chalasani, Eduardo Vilar‐Gómez, Rohit Loomba, et al.
Hepatology (2024) Vol. 80, Iss. 5, pp. 1212-1226
Closed Access | Times Cited: 11
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 11
Screening for liver fibrosis: lessons from colorectal and lung cancer screening
Maja Thiele, Patrick S. Kamath, Isabel Graupera, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 517-527
Closed Access | Times Cited: 9
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Machine-learning–based plasma metabolomic profiles for predicting long-term complications of cirrhosis
Chengnan Guo, Zhenqiu Liu, Hong Fan, et al.
Hepatology (2024)
Closed Access | Times Cited: 7
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
Tae‐Hwi Schwantes‐An, John B. Whitfield, Guruprasad P. Aithal, et al.
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 7
Abdominal obesity and alcohol use modify the impact of genetic risk for incident advanced liver disease in the general population
Panu K. Luukkonen, Martti Färkkilâ, Antti Jula, et al.
Liver International (2023) Vol. 43, Iss. 5, pp. 1035-1045
Open Access | Times Cited: 14
Efficacy of Non-invasive Biomarkers in Diagnosing Non-alcoholic Fatty Liver Disease (NAFLD) and Predicting Disease Progression: A Systematic Review
Sheenam Garg, Mansey Varghese, F Shaik, et al.
Cureus (2025)
Open Access
Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
Jingru Song, Z. Gao, Ling‐Ping Lai, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Alcohol Intake and Cardiometabolic Risk Factors Are Independently Associated With a Higher AST/Platelet Ratio Index in Obese Males
Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, et al.
Liver international communications. (2025) Vol. 6, Iss. 1
Open Access
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease
Lorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 8, pp. 1072-1080
Open Access | Times Cited: 10
Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
Mădălina-Gabriela Țâru, Monica Lupșor‐Platon
Cancers (2023) Vol. 15, Iss. 16, pp. 4097-4097
Open Access | Times Cited: 9
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly P. Mendoza, et al.
Hepatology (2024) Vol. 80, Iss. 4, pp. 887-900
Closed Access | Times Cited: 3
Integrating PNPLA3 into clinical risk prediction
Vincent Chen, Umberto Vespasiani‐Gentilucci
Liver International (2024)
Open Access | Times Cited: 2
Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
Theodora Oikonomou
Annals of Gastroenterology (2023)
Open Access | Times Cited: 5
Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk?
Umberto Vespasiani‐Gentilucci, Luca Valenti, Stefano Romeo
Liver International (2023) Vol. 43, Iss. 10, pp. 2052-2054
Open Access | Times Cited: 5
Editorial: Genetics for non‐invasive risk stratification—Finding the needle in the haystack?
Vincent Chen
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 407-408
Closed Access | Times Cited: 1
Serum Branched-Chain Amino Acids and Long-Term Complications of Liver Cirrhosis: Evidence from a Population-Based Prospective Study
Yichen Zhu, Chengnan Guo, Hong Fan, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2295-2295
Open Access | Times Cited: 1
Outcome prediction in metabolic dysfunction‐associated steatotic liver disease using stain‐free digital pathological assessment
Timothy J. Kendall, Elaine Chng, Yayun Ren, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2511-2516
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top